K K Matthay
Overview
Explore the profile of K K Matthay including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
112
Citations
3764
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Phase I/II study of (131)I-MIBG with vincristine and 5 days of irinotecan for advanced neuroblastoma
Dubois S, Allen S, Bent M, Hilton J, Hollinger F, Hawkins R, et al.
Br J Cancer
. 2015 Jan;
112(4):644-9.
PMID: 25602966
Background: (131)I-metaiodobenzylguanidine (MIBG) is an active radiopharmaceutical in neuroblastoma. A previous study demonstrated that MIBG could be combined with vincristine and prolonged irinotecan, although 25% of first courses had grade...
2.
Dubois S, Matthay K
Q J Nucl Med Mol Imaging
. 2013 Mar;
57(1):53-65.
PMID: 23474635
Neuroblastoma is an aggressive childhood cancer, with a propensity for early widespread metastasis. Approximately 90% of tumors accumulate the norepinephrine analogue metaiodobenzylguanidine (MIBG) avidly, allowing the use of radiolabeled MIBG...
3.
Schleiermacher G, Mosseri V, London W, Maris J, Brodeur G, Attiyeh E, et al.
Br J Cancer
. 2012 Sep;
107(8):1418-22.
PMID: 22976801
Background: In the INRG dataset, the hypothesis that any segmental chromosomal alteration might be of prognostic impact in neuroblastoma without MYCN amplification (MNA) was tested. Methods: The presence of any...
4.
Porzig A, Matthay K, Dubois S, Pampaloni M, Damon L, Hawkins R, et al.
Horm Metab Res
. 2012 May;
44(7):539-42.
PMID: 22588707
Acute Respiratory Distress Syndrome (ARDS) has been reported rarely in pheochromocytoma, occurring spontaneously or after therapy with 131I-meta-iodobenzylguanidine (131I-MIBG). Our objective was to determine whether proteinuria is associated with an...
5.
Matthay K, Shulkin B, Ladenstein R, Michon J, Giammarile F, Lewington V, et al.
Br J Cancer
. 2010 Apr;
102(9):1319-26.
PMID: 20424613
Background: Neuroblastoma is an embryonic tumour of the sympathetic nervous system, metastatic in half of the patients at diagnosis, with a high preponderance of osteomedullary disease, making accurate evaluation of...
6.
Beiske K, Burchill S, Cheung I, Hiyama E, Seeger R, Cohn S, et al.
Br J Cancer
. 2009 Apr;
100(10):1627-37.
PMID: 19401690
Disseminating disease is a predictive and prognostic indicator of poor outcome in children with neuroblastoma. Its accurate and sensitive assessment can facilitate optimal treatment decisions. The International Neuroblastoma Risk Group...
7.
Taggart D, Dubois S, Matthay K
Q J Nucl Med Mol Imaging
. 2008 Dec;
52(4):403-18.
PMID: 19088694
Neuroblastoma is an embryonic tumor of the peripheral sympathetic nervous system, and is able to take up, store and secrete catecholamine metabolites. Neuro-blastoma is metastatic or otherwise high risk for...
8.
London W, Castleberry R, Matthay K, Look A, Seeger R, Shimada H, et al.
J Clin Oncol
. 2005 Aug;
23(27):6459-65.
PMID: 16116153
Purpose: In the Children's Oncology Group, risk group assignment for neuroblastoma is critical for therapeutic decisions, and patients are stratified by International Neuroblastoma Staging System stage, MYCN status, ploidy, Shimada...
9.
Ma X, Buffler P, Selvin S, Matthay K, Wiencke J, Wiemels J, et al.
Br J Cancer
. 2002 May;
86(9):1419-24.
PMID: 11986774
The relationship between daycare/preschool ("daycare") attendance and the risk of acute lymphoblastic leukaemia was evaluated in the Northern California Childhood Leukaemia Study. Incident cases (age 1-14 years) were rapidly ascertained...
10.
Shimada H, Umehara S, Monobe Y, Hachitanda Y, Nakagawa A, Goto S, et al.
Cancer
. 2001 Dec;
92(9):2451-61.
PMID: 11745303
Background: The International Neuroblastoma Pathology Classification was established in 1999 for the prognostic evaluation of patients with neuroblastic tumors (NTs). Methods: Pathology slides from 746 NTs (the Children's Cancer Group...